Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Want to turn your skills into cash? Explore ways to monetize your skills fast and increase your income.
19,311 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
MP Materials is shaping the materials landscape with its Mountain Pass operation. This guide breaks down what to wat...
A landmark, independent study finds racial disparities in AI-driven hiring tools used by major employers, affecting B...
Geopolitical tensions flare after Israel strikes Hezbollah targets in Beirut, shaking markets and prompting fresh ris...
Brookfield Asset Management is expanding its AI infrastructure pact with Bloom Energy to $25 billion, signaling a maj...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
As Walmart introduces a new chief executive in 2026, investors weigh whether the company can sustain growth, expand m...
A new wave of Gen Z investors is funding startups at live events that resemble Shark Tank, turning online reach into ...
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
Emergence AI ran five 15-day simulations using leading AI agents to test how autonomous systems could govern a synthe...
When a space company hits the public markets, unexpected names can move too. This article explains why sandisk stock ...
Two financial plans, one patient retiree, and a surprising reframe: treating Social Security as a bond changes how a ...